Chronic cyclosporine-A injection in rats with damaged blood-brain barrier does not impair retention of passive avoidance

Neuroscience Research

Volumn 32, Issue 3, 1998, Pages 195-200

  Borlongan V, Cesario ^a   Fujisaki, Tomoko ^b   Watanabe, Shigeru ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b KEIO UNIVERSITY   (Japan)

Author keywords

Blood brain barrier; Cyclosporine A; Immunosuppression; Memory retention; Neural transplantation; Passive avoidance

Indexed keywords

CYCLOSPORIN A;

ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MEMORY CONSOLIDATION; NERVE TRANSPLANTATION; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; RAT;

ANIMALS; AVOIDANCE LEARNING; BLOOD-BRAIN BARRIER; CYCLOSPORINE; FEMALE; IMMUNOSUPPRESSIVE AGENTS; MOTOR ACTIVITY; RATS; RATS, WISTAR; SODIUM CHLORIDE;

EID: 0032212055     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-0102(98)00088-1     Document Type: Article

References (27)

1. Ballarin, M., Ernfors, P., Lindefors, N., Persson, H., 1991. Hippocampal damage and kainic acid injection induce a rapid increase in mRNA for BDNF and NGF in the rat brain. Exp. Neurol. 114, 35-43.
2. Batiuk, T.D., Pazderka, F., Enns, J., De-Castro, L., Halloran, P.F., 1996. Cyclosporine inhibition of leukocyte calcineurin is much less in whole blood than in culture medium. Transplantation 61, 158-161.
3. Borlongan, C.V., Freeman, T.B., Scorcia, T.A., et al., 1995. Cyclosporine-A increases spontaneous and dopamine agonist-induced locomotor behavior in normal rats. Cell Transplant. 4, 65-73.
4. Borlongan, C.V., Stahl, C.E., Cameron, D., Saporta, S., Freeman, T.B., Cahill, D.W., Sanberg, P.R., 1996a. CNS immunological modulation of neural graft rejection and survival. Neurol Res. 18, 297-304.
5. Borlongan, C.V., Freeman, T.B., Hauser, R.A., Cahill, D.W., Sanberg, P.R., 1996b. Cyclosporine-A increases locomotor activity in rats with 6-hydroxydopamine-induced hemiparkinsonism: relevance to neural transplantation. Surg. Neurol. 46, 384-388.
6. Borlongan, C.V., Fujisaki, T., Watanabe, S., 1997a. Chronic administration of cyclospoline A does not impair memory retention in rats. NeuroReport 8, 673-676.
7. Borlongan, C.V., Koutouzis, T.K., Freeman, T.B., Hauser, R.A., Cahill, D.W., Sanberg, P.R., 1997b. Hyperactivity and hypoactivity in a rat model of Huntington's disease: the systemic 3-nitropropionic acid model. Brain Res. Protoc. 1, 253-257.
8. Borlongan, C.V., Stahl, C.E., Fujisaki, T., Sanberg, P.R., Watanabe, S., 1998. An 'immunosuppressant mechanism' for the neurotherapeutic effects of the immunosuppressant Cyclosporine-A. Amer. Soc. Neural Transplant. 4, 44.
9. Brundin, P., Nilson, O.G., Gage, F.H., Bjorklund, A., 1985. Cyclosporin A increases survival of cross-species intrastriatal grafts of embryonic dopamine-containing neurons. Exp. Brain Res. 60, 204-208.
10. Brundin, P., Widner, H., Nilsson, O.G., Strecker, R.E., Bjorklund, A., 1989. Experimental Intracerebral xenografts of dopamine neurons: the role of immunosuppression and the blood-brain barrier. Brain Res. 75, 195-207.
11. Constantini, L.C., Chaturvedi, P., Armistead, D.M., Isacson, O., 1998. A novel immunophilin ligand: distinct branching effects on dopaminergic neurons in culture and neurotrophic actions after oral administration in animal model of Parkinson's disease. Amer. Soc. Neural Transpl. Abstract 4, 40.
12. Famiglio, L., Racusen, L., Fivush, B., Solez, K., Fisher, R., 1989. Central nervous system toxicity of cyclosporine in a rat model. Transplantation 48, 316-321.
13. Fleming, L.M., Johnson, G.V.M., 1995. Modulation of the phosphorylation state of tau in situ: the roles of calcium and cyclic AMP. Biochem, J. 309, 41-47.
14. Freeman, T.B., Olanow, C.W., Hauser, R.A., et al., 1995. Bilateral fetal nigral transplantation into the postcommissural putamen in parkinson's disease. Ann. Neurol. 38, 379-388.
15. Goldfeld, A.E., Liu, P., Liu, S., Flemington, E.K., Strominger, J.L., Speck, S.H., 1995. Cyclosporin A and FK506 block induction of the Epstein-Barr virus lytic cycle by anti-immnoglobulin. Virology 209, 225-229.
16. Kordower, J.H., Freeman, T.B., Snow, B.J., et al., 1995. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fatal mesencephalic tissue in a patient with Parkinson s disease. New Eng. J. Med. 332, 1118-1124.
17. Matsuura, K., Kabuto, H., Makino, H., Ogawa, N., 1996. Cyclosporin A attenuates degeneration of dopaminergic neurons induced by 6-hydroxydopamine in the mouse brain. Brain Res. 733, 101-104.
18. Matsuura, K., Makino, H., Ogawa, N., 1997. Cyclosporin A attenuates the decrease in tyrosine hydroxylase immunoreactivity in nigrostriatal dopaminergic neurons and in striatal dopamine content in rats with intrastriatal injection of 6-hydroxydopamine. Exp. Neurol. 146, 526-535.
19. Nieto-Sampedro, M., Cotman, G.W., 1985. Growth factor induction and temporal order on central nervous system repair. In: Cotman, G.W. (Ed.), Synaptic Plasticity. Academic Press, New York, pp. 407-455.
20. Nieto-Sampedro, M., Whittemore, S.R., Needels, D.L., Larson, J., Cotman, C.W., 1984. The survival of brain transplants is enhanced by extracts from injured brain. Proc. Natl. Acad. Sci. 81, 6250-6254.
21. Norman, A.N., Bertram, K.J., Thomas, R.A., Pratt, R.G., 1991. Magnetic resonance imaging of rat brain following in vivo disruption of the cerebral vasculature. Brain Res. Bull 26, 593-597.
22. Racusen, L., Famiglio, L., Fivush, B., Olton, D.S., Solez, K., 1988. Neurologic abnormalities and mortality in rats treated with cyclospoline A. Transpl. Proc. 3, 934-936.
23. Stahl, C.E., Fujisaki, T., Borlongan, C.V., Watanabe, S., 1997. Memory retention and calcineurin activity following chronic administration of immunosuppresant Cyclosporine-A. Intl. Soc. Neural Transpl Abstract 6, 51.
24. Steiner, J.P., Connolly, M.A., Valentine, H.L., et al., 1997. Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin, and cyclosporin. A. Nat. Med. 3, 421-428.
25. Widner, H., Brundin, P., Bjorklund, A., Moller, E., 1989. Survival and immunogenicity of dissociated allogenic fetal neural dopamine-rich grafts when implanted into the brains of adult mice. Exp. Brain Res. 76, 187-197.
26. Zavyalov, V.P., Denesyuk, A.I., Lundell, J., Korpela, T., 1995. Some new aspects of molecular mechanisms of cyclosporin A on immune response, A.P.M.I.S. 103, 401-415.
27. Zhang, J., Steiner, J.P., 1995. Nitric oxide synthase immunophilins and poly (ADP-ribose) synthetase: novel targets for the development of neuroprotective drugs. Neurol. Res. 17, 285-288.